Last update:

Oncology & Cancer news

Oncology & Cancer

Investigating how tumor-immune cell clusters drive breast cancer spread

In a pair of studies, investigators from the lab of Huiping Liu, MD, Ph.D., associate professor of Pharmacology and of Medicine in the Division of Hematology and Oncology, have uncovered how specific cellular interactions ...

Oncology & Cancer

Stronger together: A new fusion protein boosts cancer immunotherapy

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein ...

Oncology & Cancer

Lymph nodes found to be key to successful cancer immunotherapy

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against ...

Oncology & Cancer

Blood test to rule out esophageal cancer

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out esophageal adenocarcinoma ...

Oncology & Cancer

Getting the facts on ovarian cancer

Ovarian cancer is relatively rare. However, it's often fatal in later stages of the disease. The cancer begins in the ovaries and spreads to the abdomen and pelvis if it isn't diagnosed and treated early. It primarily affects ...

Oncology & Cancer

As pesticides and wildfires rise, kids with cancer need resources

A growing body of research ties environmental pollutants to worse health and shorter life spans for childhood cancer survivors. Yet medical providers lack sufficient resources to address these risks with patients, a recent ...

Oncology & Cancer

Biomarkers linked to side effects from cancer immunotherapy

A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy. ...

Oncology & Cancer

Research links DNA replication failure to cancer therapy

A new study from Karolinska Institutet, published in Nature Communications, reveals that cyclin-dependent kinases (CDK) promote DNA replication licensing in human cells by relieving inhibitory signals from RB tumor suppressor ...

Medical research

Microbial allies: Bacteria help fight against cancer

An international team of scientists led by researchers at the MRC Laboratory of Medical Sciences (LMS), Imperial College London and the University of Cologne have discovered that microbes associated with tumors produce a ...

Oncology & Cancer

Using deep learning for precision cancer therapy

Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the treatment methods from which ...

Oncology & Cancer

AI matches dermatologists in assessing common skin cancer

A simple AI model has been shown to perform on a par with experienced dermatologists when assessing the aggressiveness of a common form of skin cancer, squamous cell carcinoma. The research was headed by the University of ...

Oncology & Cancer

Surprising new roles discovered for known blood cancer gene DNMT3A

A gene called DNMT3A is important for guiding blood stem cells into forming all the cell types present in blood, including red blood cells, white blood cells and platelets. When this gene accumulates mutations—which might ...

Oncology & Cancer

New treatments found for tough blood cancers

Researchers from King's have identified a new way to treat certain blood cancers using existing drugs, by turning a once-dismissed part of our DNA into a therapeutic target.

Medications

FDA approves Inlexzo for bladder cancer

The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.

Oncology & Cancer

How small cell lung cancer hijacks neuronal synapses

An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body's neural circuits to grow faster. The finding reveals a startling new dimension of ...

Oncology & Cancer

Repurposing a diabetes medication to prime CAR T cancer targets

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United States. Despite recent advances, the 5-year survival rate for metastatic UC remains about 5% to ...